Xepi for treating Impetigo

Xepi (ozenoxacin) is a topical non-fluorinated quinolone for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes. Xepi is usually applied as a thin layer to the affected area twice daily for five days.

Impetigo is a highly contagious bacterial skin infection. Always use Xepi as directed by your healthcare practitioner. Wash your hands after applying the cream if the hands are not the area for treatment.

Xepi is for external use only. Do not swallow the cream, or use it in the eyes, on the mouth or lips, inside the nose, or inside the female genital area. The treated area may be covered by a sterile bandage or gauze dressing.

Use Xepi for the entire time as recommended by your healthcare practitioner, even though your symptoms may have improved. Notify your healthcare practitioner if there is no improvement in symptoms within three days of starting treatment.
          haleplushearty.blogspot.com

Genome editing improves T-cell for cancer immunotherapy

Researchers have discovered a way to boost the cancer-destroying ability of the immune system's T-cells, offering new hope in the fight against a wide range of cancers. Using CRISPR genome editing, the team took the genetic engineering of killer T-cells one step further by removing their non- cancer specific receptors and replacing them with ones that would recognize specific cancer cells and destroy them.T-cells engineered to fight cancer had two kinds of receptors – the therapeutic one that was added in the lab, and their own naturally existing one.

Since there is only limited 'space' on a cell for receptors, cancer-specific ones need to compete with the cell's own receptors to perform their function. More often than not, the cell's own receptors win that competition, and leave 'space' for only a very limited number of newly introduced, cancer-specific receptors, which means that T-cells engineered with the current technology never reach their full potential as cancer killers. The T-cells we made using genome editing do not have any of their own T-cell receptors left, and therefore the only receptor they can use is the one specific for cancer. As a result, these cells can be  better at seeing and killing cancer than the cells prepared using the current methodology.

T-cells are a part of the immune system that helps human to fight off bacterial and viral infections, such as the flu virus. Some T-cells are also able to attack cancer cells. Augmenting and harnessing the anti-cancer activity of the body's own T-cells has led to the development of so-called immunotherapies which are now transforming the field of cancer treatment, even giving hope to patients with final stage disease.

The team believe that in time new improvements in gene editing technology are set to revolutionise cancer immunotherapy, making the treatments, which are unprecedented in their effectiveness, applicable to wider cohorts of patients suffering from different types of the disease. The improvement in the sensitivity of cancer recognition that can be achieved by editing out the existing natural receptor and then replacing it with one that sees cancer cells is remarkable. Immunotherapy-harnessing the body´s own immune cells has become the most potent and promising new treatment for a range of cancers and represents one of the biggest breakthroughs in cancer treatment.
         haleplushearty.blogspot.com

Benefits of chewing foods

Chewing foods properly before you swallow boosts the mouth's immune system and protects against illness.

Th17 immune cell is triggered by chewing, it protects against bacterial and fungal infections that are on the tongue and teeth.

Those who chewed each mouthful food for 40 times ate less than those who chewed for just 15 times.

Chewing for longer prevents over-eating by giving the brain signals from the stomach that it is full. It also lowers the levels of ghrelin, the hunger hormone.

      haleplushearty.blogspot.com

When liver immune cells are weak

Fatty diet and obesity destroy liver immune system and result in type 2 diabetes.

Researchers at Toronto General Hospital Research Institute used mice cells and human livers to discover why liver of diabetes patients produce much glucose.

They discovered that obesity and fatty diet increased blood sugar, liver cells become pathogenic and destroy immune system.

Researchers fed mice with fatty diet for 4 months, they compared them with other mice and discovered that increased triglycerides in their blood and increase in CD8+ T cells in the liver.

The CD8+ T cells caused an inflammatory to bacterial components that moved to liver from the gut through the blood.